Nautilus Biotechnolgy Inc. (NASDAQ: NAUT)
$1.6700
-0.0200 ( -2.34% ) 34.7K
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. It has built a prototype of a single-molecule instrument, Proteomic Analysis System.
Market Data
Open
$1.6700
Previous close
$1.6900
Volume
34.7K
Market cap
$210.95M
Day range
$1.6700 - $1.7400
52 week range
$1.6100 - $3.2500
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 10-q | Quarterly Reports | 65 | Oct 29, 2024 |
| 8-k | 8K-related | 14 | Oct 29, 2024 |
| 4 | Insider transactions | 1 | Sep 25, 2024 |
| 4 | Insider transactions | 1 | Sep 18, 2024 |
| 3 | Insider transactions | 3 | Sep 17, 2024 |
| 4 | Insider transactions | 1 | Sep 17, 2024 |
| 8-k | 8K-related | 14 | Jul 30, 2024 |
| 10-q | Quarterly Reports | 63 | Jul 30, 2024 |
| 4 | Insider transactions | 1 | Jun 17, 2024 |
| 4 | Insider transactions | 1 | Jun 17, 2024 |